Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.

导出原文传递

翻译打印收藏纠错

作者： Tiana S,Luczak ^[1] ; Paul J,Schillo ^[2] ; Colleen M,Renier ^[2] ; Stephen C,Waring ^[2] ; Bret B,Friday ^[2]

作者单位： Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, College of Pharmacy, Duluth, MN, USA. ^[1] Essentia Health, Duluth, MN, USA. ^[2]

关键词 Pharmacogenetics colorectal cancer implementation

主题词结直肠肿瘤(Colorectal Neoplasms);可行性研究(Feasibility Studies);人类(Humans);遗传药理学(Pharmacogenetics)

DOI 10.1177/10781552211005529

PMID 33853470

发布时间 2022-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of oncology pharmacy practice

2022年28卷4期

842-849页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

检索历史清除